cancer panel Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium The company is getting ready to offer cancer patients every type of molecular cancer diagnostics, including testing for minimal residual disease. Exact Sciences Q4 Revenues up 58 Percent; Company to Acquire Ashion Analytics From TGen Exact's planned acquisition of Ashion, a sequencing lab based in Arizona, builds on the company's licensing of the TARDIS liquid biopsy technology from TGen in January. UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing Premium Spun out of the Glasgow Precision Oncology Laboratory, Gabriel wants targeted sequencing to become the norm for all somatic cancer patients. M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Although the total number of deals went down in 2020, those deals were worth more compared to 2019 — four of the top five had billion-dollar price tags. Multigene Panel Germline Testing of Cancer Patients Detects Unexpected Pathogenic Variants Premium The study, presented at the NSGC annual conference last week, supports the broader use of panel testing for cancer patients suspected of hereditary disease. Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Mar 31, 2020 The Decade in Genomics: CRISPR, Single Cells, Long Reads, Clinical and Consumer Applications Premium Mar 12, 2020 Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications Feb 13, 2020 Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel Feb 11, 2020 New Algorithms Unlock Targeted Sequencing on Nanopore Platforms Premium Jan 16, 2020 Illumina Targets Single-Cell, Oncology Applications With New NextSeq Platform Premium Dec 19, 2019 Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors Dec 11, 2019 At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations Dec 6, 2019 Gene Panel Finds Pathogenic Variants Missed by Standard Tests in 5 Percent of Familial Cancer Cases Sep 24, 2019 Foundation Medicine, Natera to Develop Liquid Biopsy Monitoring Assays Sep 5, 2019 Large-Scale Multigene Panel Study of Hereditary Cancer Risk Refines Gene Associations Premium Jun 20, 2019 On Heels of $200M Cash Infusion, Tempus Enters Major Growth Phase Premium Apr 2, 2019 Nordic Countries Invest $19M in Personalized Medicine Research Projects Premium Mar 21, 2019 Roche Gets CE Mark for Mutation Profiler Software for NGS Cancer Tests Mar 15, 2019 Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine Premium Feb 5, 2019 Foundation Medicine Gets $111.5M Genomic Profiling Contract From VA Department Jan 14, 2019 Tumor Hypoxia Associated With Cancer Driver Mutation Signatures in 19 Tumor Types Jan 11, 2019 Foundation Medicine Says Tumor Mutational Burden Reporting Issue on CDx Test Is Resolved Jan 8, 2019 Illumina to Launch New NovaSeq Chip, iSeq Kit; Grow Oncology and Reproductive Health Business Dec 3, 2018 NGeneBio Raises $11M Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.